# Stop Air Leak by Talc or Autologous Blood Patch Therapy

> **NCT06883188** · PHASE2,PHASE3 · NOT_YET_RECRUITING · sponsor: **Chinese University of Hong Kong** · enrollment: 30 (estimated)

## Conditions studied

- Pneumothorax Spontaneous Secondary

## Interventions

- **DRUG:** talc powder
- **BIOLOGICAL:** patient's own venous blood

## Key facts

- **NCT ID:** NCT06883188
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-01
- **Primary completion:** 2029-03-31
- **Final completion:** 2029-03-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06883188

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06883188, "Stop Air Leak by Talc or Autologous Blood Patch Therapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06883188. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*